Clinical trial
Rho Kinase in Patients With Atherosclerosis
NCT00115830 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00115830 |
|---|---|
| Title | Rho Kinase in Patients With Atherosclerosis |
| Official title | Rho Kinase in Patients With Atherosclerosis: Effects of Statins - A Double Blind, Randomized Clinical Trial Comparing Rosuvastatin and Atorvastatin |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | Atorvastatin, Rosuvastatin |
| Enrollment | 40 |
| Start date | Dec 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Jun 27, 2005 |
| Last update posted | Apr 24, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: